A research team has shown how the presence of type 2 diabetes increased the likelihood of more depressive symptoms, and in turn, the higher the levels of depressive symptoms, the higher the prevalence of type 2 diabetes.
Type 2 diabetes linked to increased depressive symptoms Read More »
This grant allows the UICEC to remain one of the 27 clinical research support units that make up the ISCIII platform.
The association based in the Baix Llobregat has been collaborating with IDIBELL since 2016, collecting funds for cancer research.
Collaborative success in advancing stroke neuroprotection
The renowned Dr. Kerri Johannson, a member of the Snyder Institute for Chronic Diseases at Canada’s University of Calgary, gave an IDIBELL seminar on January 12 at the Bellvitge Campus on the impact of environmental exposures on patients with pulmonary fibrosis.
A research group from IDIBELL and ICO have presented an oncolytic virus that stimulates the anti-tumor response of NK cells and helps slow the growth of cancer.
Scientists present an oncolytic virus targeting NK cells with great antitumor potential Read More »
A study published in Circulation offers unprecedented perspectives on the molecular mechanisms that lead to Hereditary Hemorrhagic Telangiectasia
Scientists find a new mechanism that explains the development of vascular malformations Read More »
It is one of the winning initiatives of the 2023 call for grants, which is the result of a collaboration agreement between the charity institution and the council.
The grant, of €2,500,000, will promote the Smart Health Community project
IDIBELL receives FORTALECE grant from the Carlos III Health Institute Read More »
The use of this massive genetic sequencing platform could improve patient survival thanks to the detection of therapeutic targets and mutations that predispose to cancer.
